ABC | Volume 110, Nº6, Junho 2018

Artigo Original Marui et al Variáveis pressóricas na doença de Duchenne Arq Bras Cardiol. 2018; 110(6):551-557 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 20. AmericanAcademyofPediatrics,SectiononCardiologyandCardiacSurgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005;116(6):1569-73. 21. National High Blood Pressure Education ProgramWorking Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555-76. 22. O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. European SocietyofHypertensionWorkingGrouponBloodPressureMonitoring.Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressuremeasurement. J Hypertens. 2005;23(4):697-701. 23. Masood SA, Kazmouz S, Heydemann P, Li H, Kenny D. Under-recognition of Low Blood Pressure Readings in Patients with Duchenne Muscular Dystrophy. Pediatr Cardiol. 2015;36(7)1489-94. 24. Malachias MV, Souza WK, Plavnik FL, Rodrigues CI, Brandão AA, Neves MF, et al; Sociedade Brasileira de Cardiologia. 7a Diretriz Brasileira de hipertensão arterial. Arq Bras Cardiol. 2016;107(3 supl 3):1-83. 25. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al; DMDCare Considerations Working Group. Diagnosis and management of Duchennemuscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177-89. 26. Loufrani L, Levy BI, Henrion D. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ Res. 2002;91(12):1183-9. 27. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, Victor RG. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci USA. 1998;95(25):15090-5. 28. Thomas GD, Shaul PW, Yuhanna IS, Froehner SC, Adams ME. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha- syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase. Circ Res. 2003;92(5):554-60. 29. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995;82(5):743-52. 30. ChangWJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, et al. Neuronalnitricoxidesynthaseanddystrophin-deficientmusculardystrophy. Proc Natl Acad Sci USA. 1996;93(17):9142-7. 557